W&M Chair Eyes Reimbursement Tweaks, Tax, Trade Policies To Stem Drug Shortages

By Maaisha Osman / February 7, 2024 at 1:49 PM
House Ways & Means Chair Jason Smith (R-MO) urges bipartisan action to tackle drug shortages, suggesting lawmakers weigh solutions that include revisions to Medicare reimbursement, long-term contracts with manufacturers, state-funded buffer supplies of drugs, and trade and tax policies that incentivize domestic drug production. "Medicare’s reimbursement system ensures affordability and access for seniors, but should be reexamined to avoid making this situation worse,” said Smith in his opening remarks at a Ways & Means drug shortage hearing Tuesday (Feb. 6)...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.